DECK

Business Context and Reporting Period

Company: Deckers Outdoor Corp
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2001
Business Overview: The Company designs and markets innovative footwear under three primary brands: Teva (high-performance sports sandals and outdoor footwear), Simple (casual lifestyle footwear), and Ugg (sheepskin boots). In 2001, the Company sold approximately 3.7 million pairs of footwear. Manufacturing is conducted overseas, primarily in China, Australia, and New Zealand.

Key Financial Metrics

Segment Performance (2001):

• Teva: Sales of $61.2 million (66.9% of total); Operating earnings of $12.4 million.
• Simple: Sales of $10.9 million (11.9% of total); Operating earnings of $0.2 million.
• Ugg: Sales of $19.2 million (21.0% of total); Operating earnings of $3.7 million.

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased by $22.3 million (19.6%) primarily due to weakness in the domestic economy, a soft retail environment, reduced international sales, and colder weather impacting Teva sandal demand. The bankruptcy of a major customer, Track 'n Trail, also contributed to the decline.
• Margin Compression: Gross margin decreased to 42.2% from 44.1% due to increased closeout sales and lower pricing on the 2001 product line to address competitive pressures.
• Operating Expenses: Selling, general, and administrative (SG&A) expenses decreased by $3.5 million (9.4%) due to lower commissions, royalties, and marketing costs. However, SG&A as a percentage of sales increased to 37.2% due to fixed costs not declining proportionally with sales.
• One-Time Litigation Charge: The Company recorded a $2.2 million charge in 2001 related to the final settlement of the "Molly" litigation, which was affirmed by the Court of Appeals.
• Asset Sale: In January 2001, the Company sold its 50% interest in Heirlooms, Inc. (Picante clothing) for approximately $1.6 million, resulting in the exclusion of approximately $2.3 million in sales from the 2001 comparison.

Guidance, Outlook, and Risks

Outlook and Guidance (2002)

• Sales Expectations: Management expects 2002 net sales to range from $88 million to $91 million. This includes projected Teva sales of $58–$60 million, Simple sales of approximately $10 million, and Ugg sales of $20–$21 million.
• Earnings Expectations: Excluding the impact of new accounting standards (SFAS 142), diluted EPS is expected to range from $0.17 to $0.20. Including the cumulative effect of SFAS 142 (goodwill impairment), the Company expects a net loss per share of approximately $0.75 to $0.78.
• Seasonality: Sales are expected to be lower in the first half of 2002 compared to 2001, with anticipated gains in the third and fourth quarters driven by the Ugg brand and new Teva fall lines.

Material Risks and Contingencies

• Teva License Agreement: The Company licenses the Teva brand from Mark Thatcher. The license requires minimum annual sales of $107.9 million in 2004 and $137.3 million in 2008 to renew. With 2001 sales at $61.2 million, the Company believes it is unlikely to meet the 2004 minimum. Failure to meet this threshold would result in the loss of the Teva license, which accounted for 66.9% of 2001 sales.
• Acquisition Option: The Company holds an option to acquire Teva assets. Exercising this option would require significant financing and eliminate royalty payments (approx. 5-6.5% of sales).
• Legal Proceedings:
  • Molly Litigation: Settled for $2.0 million in 2001; potential exposure for additional fees/damages up to $2.5 million remains.
  • Dutch Distributor: Litigation regarding breach of contract; potential exposure up to $500,000.
  • Anti-Dumping Duties: Potential exposure of $500,000 for unpaid European anti-dumping duties from 1997, which has been fully accrued.
• Accounting Changes: Implementation of SFAS 142 in 2002 is expected to result in a goodwill impairment charge of approximately $9.8 million ($9.0 million after tax), primarily related to Ugg and Simple intangible assets.

Investor Verification Checklist

• Teva License Status: Verify the outcome of negotiations with Mark Thatcher regarding the 2004 sales minimums and the potential exercise of the acquisition option.
• Goodwill Impairment: Confirm the final calculation of the SFAS 142 impairment charge expected in Q1 2002 and its impact on 2002 net income.
• Inventory Levels: Review inventory turnover and obsolescence reserves, given the 7.5% increase in inventory and the history of closeout sales impacting margins.
• Customer Concentration: Monitor the financial health of key retail customers, particularly following the bankruptcy of Track 'n Trail.
• Legal Reserves: Track developments in the Molly litigation (potential additional damages) and the Dutch distributor dispute.